CAS: 4282-42-2; 1-Iodononane

该化合物是一种高纯基烷基碘化合物,通常用于有机合成,特别是在诸如Heck,Negishi和Suzuki-Miyaura等交叉反应中. 添加铜作为稳定剂,通过尽量减少光分解或氧化降解而提高其储存寿命. 该化合物因其作为电焊剂的再活性及其在将非基类分子引入目标分子中的效用而得到估价. 其稳定的配方确保了在要求应用方面的一贯性能,使它成为制药,农用化学和材料科学研究的可靠选择. 建议在惰性条件下进行适当的惰性储存以保持稳定性.

结构式图片

相似化合物

4282-40-0 629-93-6 544-77-4

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号16979-32-1 1-ethoxynonane | CAS号143-08-8 1-壬醇 | CAS号124-11-8 壬烯 | CAS号20633-13-0 Nonylnitrate | CAS号124-19-6 正壬醛 | CAS号45206-91-5 7-十六烷酮 | CAS号593-08-8 2-十三烷酮 | CAS号593-45-3 正十八烷 | CAS号929-98-6 二壬基硫醚 | CAS号50262-46-9 4-正壬氧基苯甲醛 | CAS号872-05-9 正癸烯 | CAS号2456-27-1 dinonyl ether | CAS号24323-25-9 2-甲基十一烷酸 | CAS号111-84-2 正壬烷 | CAS号152634-09-8 1,2-di(nonoxy)b...

合成工艺路线路线简述

    📜正癸酸置于n-碘代丁二酰亚胺,碘体系中,用 1,2-二氯乙烷 作为反应溶剂,化学反应 8.0H,以90%的收率获得产物1-碘壬烷
    参考文献:用 Nis 和 Ncs/nai 将脂肪族羧酸一锅法转化为 N-烷基琥珀酰亚胺
    标题:用 Nis 和 Ncs/nai 将脂肪族羧酸一锅法转化为 N-烷基琥珀酰亚胺
    摘要:在加热条件下,用 N-碘代琥珀酰亚胺 (Nis)置于1,2-二氯乙烷中处理初级脂肪族羧酸以形成相应的烷基碘.基于这些结果,这些脂肪族羧酸用 Nis 处理,然后与 K2Co3 反应,在一锅中以非常好的收率得到相应的 N-烷基琥珀酰亚胺.此外,这些脂肪族羧酸用 N-氯代琥珀酰亚胺 (Ncs) 和 Nai 处理,然后与 K2Co3 反应以在一锅中以非常好到中等的收率提供相应的 N-烷基琥珀酰亚胺.通过使用本方法,用 Nis,K2Co3 和肼连续处理伯脂肪族羧酸 (10 Mmol),然后以非常好的收率提供相应的脱羧伯胺.
    DOI:10.1002/ejoc.201501315

    海关参考信息

    专利信息


    专利号:US-5948903-A
    优先权日:1991-01-11
    标题:Synthesis of 3-deazapurines
    发明人:COOK P DAN; ACEVEDO OSCAR L; ANDREWS ROBERT S
    权利人:ISIS PHARMACEUTICALS INC
    摘要:This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of 'antisense' agents, agents that are capable of specific hybridization with a nucleotide sequence of an RNA. The 3-deazapurine-containing compounds of this invention can be useful for modulating the activity of RNA when incorporated into oligonucleotides. Oligonucleotides and their analogs are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins and cleaving RNA in site specific fashions.

    专利号:US-5098602-A
    优先权日:1988-05-11
    标题 :Novel halogen-containing ester compounds, and their intermediates, and method of producing the same as well as liquid crystal compositions containing the same and light switching elements
    发明人:HIRAI TOSHIHIRO; YOSHIZAWA ATSUSHI; NISHIYAMA ISA; FUKUMASA MITSUO; SHIRATORI NOBUYUKI; YOKOYAMA AKIHISA
    权利人:NIPPON MINING CO
    摘要:This invention provides a novel halogen-containing ester compound represented by the following general formula (I): ##STR1## (wherein R is an alkyl group, A is selected from a single bond, --O--, --COO-- and --CO--, both of X and Y are halogen atoms or either one of X and Y is a halogen atom and the other is a hydrogen atom, each of m and n is 0 or 1, m+n=0 or 1, each of k and l is an integer of 1 or more, provide k
    专利号:US-5750692-A
    优先权日:1990-01-11
    标 题 :Synthesis of 3-deazapurines
    发明人:COOK P DAN; ACEVEDO OSCAR L; ANDREWS ROBERT S
    权利人:ISIS PHARMACEUTICALS INC
    摘要:This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of 'antisense' agents, agents that are capable of specific hybridization with a nucleotide sequence of an RNA. The 3-deazapurine-containing compounds of this invention can be useful for modulating the activity of RNA when incorporated into oligonucleotides. Oligonucleotides and their analogs are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins and cleaving RNA in site specific fashions.

    专利号:EP-4065643-B1
    优先权日:2019-11-28
    标题 :Fluorescent acridinium salts, synthesis thereof and use for detection of cardiolipin
    发明人:ARSENJANS PAVELS; DIMITRIJEVS PAVELS
    权利人:LATVIAN INST ORGANIC SYNTHESIS

    专利号:US-4940712-A
    优先权日:1989-05-26
    标 题 :Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
    发明人:WALKER FREDERICK J; MELVIN LAWRENCE S
    权利人:PFIZER
    摘要:2-Amino and 2-thio-4-substituted-5-(hydroxy or alkoxy)-pyrimidines, which may be 6-substituted, and derivatives thereof are disclosed. The compounds are inhibitors of leukotriene synthesis and are, therefore, useful for the treatment of pulmonary, inflammatory, dermatological, allergic and cardiovascular diseases. The compounds are also cytoprotective and therefore, useful in the treatment of peptic ulcers.

    专利号:US-2021237040-A1
    优先权日:2018-06-26
    标题:Metal-iodide catalytic system for direct etherification from aldehydes and/or ketones
    发明人:WU DAN; ORDOMSKY VITALY; HERNANDEZ ENCISO WILLINTON YESID; STREIFF STÉPHANE
    权利人:RHODIA OPERATIONS; CENTRE NAT RECH SCIENT; UNIV DE LILE; CENTRALE LILLE INST
    摘要:A process for etherification of aldehydes and/or ketones in the presence of a catalyst and an iodine source. In particular, a process for the synthesis of an ether compound, comprising reacting an aldehyde and/or a ketone with an alcohol, in the presence of (i) a metal/support heterogeneous catalyst and an iodine source, or (ii) a metal-iodine catalyst, in a reactor, whereby the ether compound is obtained. A catalytic system comprising a metal/support heterogeneous catalyst and an iodine source, and a process for its preparation.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Fiona J Black, Et Al. Synthesis Of Phalluside-1 And Sch Ii Using 1,2-Metallate Rearrangements. Org Biomol Chem. 2010 Mar 7;8(5):1188-93.

    合成参考文献


    摘要:Kwiecień, H. U., Science of Synthesis: Knowledge Updates, (2024) 3, 187.
    参考文献:10.4061/2011/384213
    摘要:Legakis I, Syrigos K. Recent Advances in Molecular Diagnosis of Thyroid Cancer. Journal of Thyroid Research. 2011;2011():1–8. doi: 10.4061/2011/384213.
    参考文献:10.1097/00006231-200409000-00005
    摘要:AL-Nahhas A. Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals. Nuclear Medicine Communications. 2004 Sep;25(9):891–5. doi: 10.1097/00006231-200409000-00005.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知